Screener
Lexicon Pharmaceuticals LXRX Compensation and benefits
Compensation and benefits at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The source filing: Lexicon Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001062822-26-000117
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Net loss | $(32,818) | $(22,043) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 212 | 352 |
| Stock-based compensation | 6,414 | 6,238 |
| Amortization of debt-related costs | 1,213 | 803 |
| Loss on early extinguishment of debt | 4,349 | — |
| Accretion of marketable securities purchased at a discount | (1,292) | (2,540) |
| Other non-cash adjustments | (99) | (1,561) |
Item 1. Financial Statements
FAQ
- What is Lexicon Pharmaceuticals's compensation and benefits?
- Lexicon Pharmaceuticals (LXRX) reported compensation and benefits of $3.34M in Q2 2026.
- How has Lexicon Pharmaceuticals's compensation and benefits changed year-over-year?
- Lexicon Pharmaceuticals's compensation and benefits increased by 4.4% year-over-year, from $3.2M to $3.34M.
- What is the long-term trend for Lexicon Pharmaceuticals's compensation and benefits?
- Over 4 years (2021 to 2025), Lexicon Pharmaceuticals's compensation and benefits has grown at a 4.3% compound annual growth rate (CAGR), from $10.58M to $12.52M.
- What does compensation and benefits mean?
- Total employee-related costs including salaries, wages, bonuses, commissions, stock-based compensation, health insurance, retirement contributions, and payroll taxes.
Ask your AI about Lexicon Pharmaceuticals's compensation and benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude